Philips has teamed up with Myocardial Solutions, a US-based provider of cardiac imaging technologies, to advance cardiac magnetic resonance (CMR) imaging using AI solutions.

The collaboration aims to improve survival rates and enhance the quality of life for people undergoing cancer treatment, bridging a gap between heart and cancer care.

According to the Dutch medical technology company, early detection of heart disease may benefit cancer survivors taking treatment for cardiotoxicity, caused due to cancer therapies.

Both companies leverage advanced imaging technologies, such as Fast-SENC and MyoStrain, to detect early signs of cardiotoxicity in patients undergoing cancer treatments.

By measuring subtle changes in heart function, the technologies enable early detection of heart failure across 48 heart segments in 10 minutes.

With less than five minutes of analysis time, the analysis helps identify regional dysfunction before the affects the entire heart, said the medical technology company.

Philips MR business leader Ioannis Panagiotelis said: “By combining our innovative BlueSeal innovation and SmartSpeed technologies with Myocardial Solutions’ specialised expertise in cardiac care, we aim to redefine the standard of cardiac care, environmental responsibility, and accessibility.”

Philips SmartSpeed device, together with AI-powered Compressed SENSE and Adaptive-CS-Net technologies, enhances speed and reduces scan times by up to three times.

The integrated solution enables high-resolution 2D and 3D cardiac imaging across 97% of clinical protocols, while maintaining image quality.

SmartSpeed is designed to reduce CMR exams and optimise patient comfort, supporting advanced contrasts such as angiography and quantitative imaging like T1 mapping.

It enhances diagnostic confidence in challenging scenarios and enables clinicians to perform faster imaging with reduced exam times, and improved workflow efficiency and patient care.

By incorporating advanced AI reconstruction at the start of the MR signal enhances image quality, enables confident diagnostics and advances CMR applications.

Furthermore, its BlueSeal system with helium-free technology will mitigate environmental challenges by reducing helium dependency and overall carbon footprint, said Philips.